Validate
Demand testing with real buyers. Competitor and channel mapping. Regulatory and compliance pathway. Pricing and entry economics for the Australian market. We interview the people who would actually buy from you.
We become the Australian commercial arm for established international companies. We validate demand, open customer and channel relationships, and build a live pipeline on the ground. When the case is proven, we hand over to your permanent Australian leadership.
For established international companies with a proven product and no Australian commercial team. We execute — we don't write reports.
Most companies reach Australia the expensive way: hire a country manager, add a salesperson, open an entity, and commit $300,000 of payroll before anyone has met a customer. There is a step before that one.
A fixed sequence with defined outputs at each stage. You get named accounts, real meetings and a recommendation you can take to a board — not a market overview.
Demand testing with real buyers. Competitor and channel mapping. Regulatory and compliance pathway. Pricing and entry economics for the Australian market. We interview the people who would actually buy from you.
Localised proposition and commercial materials. Named target account list. Distributor, channel and partner conversations opened. First customer meetings booked and attended under your name.
Qualified pipeline with named accounts and stages. Pilots and reference prospects in motion. Twelve-month operating plan and launch budget. A clear go, no-go or wait recommendation with the numbers behind it.
Country manager brief written from live market evidence. Support through recruitment and onboarding. Structured transfer of every relationship we've opened. Your permanent leader starts with a pipeline, not a blank page.
A short, evidence-based read on whether Australia is worth your capital right now. Market sizing, competitive position, route to market, regulatory exposure and a recommended entry path.
We operate as your Australian commercial team. Validation, build and execution across three months, ending in a qualified pipeline and a board-ready recommendation.
Ongoing senior commercial leadership while you recruit, or while the market builds to the size that justifies a permanent team. Continuity of relationships through the transition.
Engagements are retainer-based with a performance-linked component. We prefer to carry some of the outcome — where it makes sense, part of our fee is structured against pipeline and first revenue rather than time. Commercial terms are set on proposal after a scoping call.
Australia is a small, concentrated market with a handful of gatekeepers in every category. Knowing who they are is the difference between ninety days of progress and ninety days of introductions.
Providers, clinics, diagnostics, medical technology, therapeutics and health services. Reimbursement, regulatory pathway and clinical channel access.
Operators, brands, suppliers and technology into hotels, resorts, venues and the wellness and longevity segment across Australia and Southeast Asia.
Products, equipment, hire and services into tier-one and tier-two builders, civil contractors, government, events and the trade channel.
Consumer hardware, appliances and branded goods through retail and distribution; B2B software and services into mid-market and enterprise buyers.
Everything we'd do for your Australian entry, we are currently doing with our own capital.
GI Asia Pacific is a privately held investment company. We own and operate three businesses across biotechnology, consumer health and concierge healthcare, in Australia and across Southeast Asia. We raise for them, hire for them, negotiate their distribution and sit on their boards.
That is a different starting point from a consultancy. We have made the entry decisions we're advising you on, in the same market, with our own money at stake. When we tell you a channel doesn't work in Australia, it's because we've tried it.
See the GI Asia Pacific portfolio →There is no delivery team behind us and no junior consultant assigned to your account. The people who meet you are the people who open the doors.
Twenty-five years building and scaling healthcare and technology businesses across Australia and Asia. Most recently General Manager of Precedence Health Care, a subsidiary of Sonic Healthcare (ASX: SHL), with full P&L responsibility.
Earlier senior roles at Unified Healthcare Group, Zedmed Medical Software and Medtech Global, and Chief Executive of LowestBid Asia based in Singapore. Bachelor of Commerce, Victoria University of Wellington.
Business development and channel leadership across the Australian construction, infrastructure and events sectors. National account and hire-network management, contractor and tender sales, and distributor development in one of Australia's most competitive B2B markets.
Deep working relationships across tier-one and tier-two builders, civil contractors, government buyers and the trade channel — the gatekeepers most international entrants never reach.
Our own companies operate across Australia and Southeast Asia. That footprint is why we can take an entry conversation beyond Australia when the regional case makes sense.
Level 2, 696 Bourke Street
Melbourne VIC 3000
Australia
Level 11, 10 Carrington Street
Sydney NSW 2000
By appointment
theDoc Health
Regional healthcare operations across Thailand, Singapore and Vietnam
Established legal, accounting and regulatory partners in each market we operate in, engaged on your behalf as required
Tell us what you sell, where you sell it now, and what's driving the Australia decision. If we're not the right fit we'll say so on the call and point you somewhere better.